Prelude Capital Management, LLC Da32 Life Science Tech Acquisition Corp. Transaction History

Prelude Capital Management, LLC

  • $1.57 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$9.59 - $9.81 $530,087 - $542,247
-55,275 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$9.76 - $10.26 $539,484 - $567,121
55,275 New
55,275 $543,000

About DA32 Life Science Tech Acquisition Corp.

DALS Quotes by TradingView
  • Ticker DALS
  • Exchange NASDAQ
  • Sector Financial Services
  • Industry Shell Companies
  • Shares Outstandng 20,650,000
  • Description
  • DA32 Life Science Tech Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company intends to identify business combination targets in the biotechnology and life science...
More about DALS
Track This Portfolio

Track Prelude Capital Management, LLC Portfolio

Follow Prelude Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prelude Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prelude Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email